Worcester HIV Vaccine
Biotechnology Research • 
Worcester, Massachusetts, United States • 1-10 Employees
Company overview
| Headquarters | Worcester, Massachusetts, United States |
| Website | |
| SIC | 283 |
| Employees | 1-10 |
| Socials |
Key Contact at Worcester HIV Vaccine
Iris Benhayoun
Director of Clinical Programs
Worcester HIV Vaccine Email Formats
Worcester HIV Vaccine uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@whvaccine.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@whvaccine.com | 66.7% |
{first initial}.{last name} | j.doe@whvaccine.com | 33.3% |
About Worcester HIV Vaccine
Worcester HIV Vaccine is a biotechnology company formed in 2018 to accelerate clinical development of the preventive HIV vaccine candidate using a polyvalent DNA-prime/protein-boost approach developed at the University of Massachusetts Medical School.
Worcester HIV Vaccine revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Worcester HIV Vaccine has never raised funding before.
Worcester HIV Vaccine Tech Stack
Discover the technologies and tools that power Worcester HIV Vaccine's digital infrastructure, from frameworks to analytics platforms.
Web servers
Font scripts
WordPress themes
JavaScript libraries
WordPress plugins
Programming languages
Hosting
Blogs
Databases
Translation
Miscellaneous
Performance
New Zealand
United Kingdom
Australia
SwitzerlandFrequently asked questions
4.8
40,000 users
